Twist Operating Margin from 2010 to 2025
| TWST Stock | USD 52.75 0.38 0.73% |
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 529.2 K, Net Interest Income of 18.5 M or Interest Income of 18.5 M, as well as many indicators such as Price To Sales Ratio of 9.15, Dividend Yield of 0.0 or PTB Ratio of 5.24. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
Twist | Operating Margin |
Latest Twist Bioscience's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Twist Bioscience Corp over the last few years. It is Twist Bioscience's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.54) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Twist Operating Margin Regression Statistics
| Arithmetic Mean | (8.26) | |
| Geometric Mean | 3.59 | |
| Coefficient Of Variation | (107.14) | |
| Mean Deviation | 8.23 | |
| Median | (2.00) | |
| Standard Deviation | 8.85 | |
| Sample Variance | 78.41 | |
| Range | 18.6002 | |
| R-Value | 0.88 | |
| Mean Square Error | 18.23 | |
| R-Squared | 0.78 | |
| Slope | 1.65 | |
| Total Sum of Squares | 1,176 |
Twist Operating Margin History
About Twist Bioscience Financial Statements
Twist Bioscience shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 989 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.